Description
Description
Quickly relieves heartburn. It takes a long time. Suitable for use during pregnancy. Pleasant mint flavor. It forms a protective barrier in the stomach, which for a long time prevents the recurrence of heartburn.
Pharmacological action of
Gaviscon ® enters the stomach and interacts with its contents, forming a protective barrier (raft), which prevents the occurrence of heartburn.
When ingested, Gaviscon ® quickly reacts with the acidic contents of the stomach. This forms an alginate gel, having an almost neutral pH value. The gel forms a protective barrier on the surface of the contents of the stomach, preventing the occurrence of gastroesophageal reflux. In case of regurgitation, the gel enters the esophagus, where it reduces irritation of the mucous membrane.
Pharmacokinetics
The mechanism of action of Gaviscon ® is a physical process and does not depend on absorption into the systemic circulation.
Indications
Symptomatic treatment of dyspepsia associated with increased acidity of gastric juice and gastroesophageal reflux (heartburn, sour belching), a feeling of heaviness in the stomach after eating, including during pregnancy.
Special instructions
At a dose of four tablets, the sodium content is 246 mg (10.6 mmol). This should be considered when dieting with a very limited salt content is necessary, for example, in some cases of congestive heart failure and with impaired renal function.
Each dose of four tablets contains 320 mg (3.2 mmol) of calcium carbonate. Caution must be exercised in the treatment of patients with hypercalcemia, nephrocalciposis, and recurrent formation of kidney stones containing calcium. Due to the content of aspartame, this drug should not be prescribed to patients with phenylketonuria. There is a possibility of reducing the effectiveness of the drug in patients with very low levels of acidity of gastric juice. If after treatment within seven days the symptoms do not disappear, then a re-evaluation of the clinical condition is necessary.
Effect on the ability to drive machinery and vehicles
The drug does not affect the ability to drive vehicles and machinery, as well as to engage in other potentially dangerous activities that require an increased concentration of attention and speed of psychomotor reactions.
Composition
Active ingredients: sodium alginate 250 mg, sodium bicarbonate 133.5 mg, calcium carbonate 80 mg
Excipients: mannitol 255 mg, macrogol 20,000 30 mg, magnesium stearate 4 mg, aspartame 3.75 mg, copovidone 28 mg, potassium acesulfame 3.75 mg , mint flavoring 12 mg.
Dosage and administration
Inside, after thorough chewing. Adults and children over 12 years of age: 2-4 tablets after meals and at bedtime (up to 4 times a day). If after 7 days of taking the drug the symptoms persist, you need to see a doctor to review the therapy. Special groups of patients Elderly patients: dose changes are not required. Patients with impaired liver function: dose changes are not required. Patients with impaired renal function: take with caution the need for a diet with a very limited salt content (see section “Special instructions”).
Side effects
Allergic reactions (urticaria, bronchospasm, anaphylactic reactions) are possible.
Drug interaction
Since calcium carbonate, which is part of the drug, exhibits antacid activity, at least 2 hours should elapse between taking Gaviscon ® and other drugs (especially when taking H2 histamine receptors, antibiotics from the tetracycline group, digoxin , fluoroquinolone, iron salts, ketoconazole, antipsychotics, thyroxine, penicillamine, beta-blockers, glucocorticosteroids, chloroquine and diphosphates).
Overdose
Symptoms: Bloating may be noted.
Treatment: symptomatic.
Storage conditions
At a temperature not exceeding 30 ° C. Keep out of the reach of children.
Expiration
2 years.
Do not use after the expiry date.
Active ingredient
Peppermint oil, Phenobarbital, Hops fruit seed, Calcium carbonate
pharmacy leave terms without a prescription
Form of Treatment
tablets dlya rassas vaniya
Rekitt Benckiser, the UK
